Activation of the transcription factor NFAT5 in the tumor microenvironment enforces CD8


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 09 09 2021
accepted: 07 08 2023
medline: 27 10 2023
pubmed: 15 9 2023
entrez: 14 9 2023
Statut: ppublish

Résumé

Persistent exposure to antigen during chronic infection or cancer renders T cells dysfunctional. The molecular mechanisms regulating this state of exhaustion are thought to be common in infection and cancer, despite obvious differences in their microenvironments. Here we found that NFAT5, an NFAT family transcription factor that lacks an AP-1 docking site, was highly expressed in exhausted CD8

Identifiants

pubmed: 37709986
doi: 10.1038/s41590-023-01614-x
pii: 10.1038/s41590-023-01614-x
doi:

Substances chimiques

Transcription Factors 0
Programmed Cell Death 1 Receptor 0
NFAT5 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1645-1653

Subventions

Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)
ID : 310030_182680
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)
ID : 310030_200898

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Blank, C. U. et al. Defining ‘T cell exhaustion’. Nat. Rev. Immunol. 19, 665–674 (2019).
pubmed: 31570879 pmcid: 7286441
Utzschneider, D. T. et al. T cell factor 1-expressing memory-like CD8
pubmed: 27533016
Speiser, D. E., Ho, P. C. & Verdeil, G. Regulatory circuits of T cell function in cancer. Nat. Rev. Immunol. 16, 599–611 (2016).
pubmed: 27526640
Thommen, D. S. & Schumacher, T. N. T cell dysfunction in cancer. Cancer Cell 33, 547–562 (2018).
pubmed: 29634943 pmcid: 7116508
Cheng, H., Ma, K., Zhang, L. & Li, G. The tumor microenvironment shapes the molecular characteristics of exhausted CD8
pubmed: 33662493
Siddiqui, I. et al. Intratumoral Tcf1
pubmed: 30635237
Baitsch, L. et al. Exhaustion of tumor-specific CD8
pubmed: 21555851 pmcid: 3104769
Lopez-Rodriguez, C., Aramburu, J., Rakeman, A. S. & Rao, A. NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. Proc. Natl Acad. Sci. USA 96, 7214–7219 (1999).
pubmed: 10377394 pmcid: 22056
Cheung, C. Y. & Ko, B. C. NFAT5 in cellular adaptation to hypertonic stress–regulations and functional significance. J. Mol. Signal 8, 5 (2013).
pubmed: 23618372 pmcid: 3655004
Kim, N. H. et al. Reactive oxygen species regulate context-dependent inhibition of NFAT5 target genes. Exp. Mol. Med. 45, e32 (2013).
pubmed: 23867654 pmcid: 3731662
Alberdi, M. et al. Context-dependent regulation of Th17-associated genes and IFNɣ expression by the transcription factor NFAT5. Immunol. Cell Biol. 95, 56–67 (2016).
pubmed: 27479742 pmcid: 5215110
Aramburu, J. & Lopez-Rodriguez, C. Regulation of inflammatory functions of macrophages and T lymphocytes by NFAT5. Front. Immunol. 10, 535 (2019).
pubmed: 30949179 pmcid: 6435587
Carmona, S. J., Siddiqui, I., Bilous, M., Held, W. & Gfeller, D. Deciphering the transcriptomic landscape of tumor-infiltrating CD8 lymphocytes in B16 melanoma tumors with single-cell RNA-seq. Oncoimmunology 9, 1737369 (2020).
pubmed: 32313720 pmcid: 7153840
Xiong, H. et al. Coexpression of inhibitory receptors enriches for activated and functional CD8
pubmed: 31064777
Jerby-Arnon, L. et al. A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade. Cell 175, 984–997 (2018).
pubmed: 30388455 pmcid: 6410377
Sade-Feldman, M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell 176, 404 (2019).
pubmed: 30633907 pmcid: 6647017
Azizi, E. et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell 174, 1293–13086 (2018).
pubmed: 29961579 pmcid: 6348010
Andreatta, M. et al. Interpretation of T cell states from single-cell transcriptomics data using reference atlases. Nat. Commun. 12, 2965 (2021).
pubmed: 34017005 pmcid: 8137700
Prevost-Blondel, A. et al. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo. J. Immunol. 161, 2187–2194 (1998).
pubmed: 9725210
Martinez-Usatorre, A. et al. Enhanced phenotype definition for precision isolation of precursor exhausted tumor-infiltrating CD8 T cells. Front .Immunol. 11, 340 (2020).
pubmed: 32174925 pmcid: 7056729
Van den Eynde, B., Mazarguil, H., Lethe, B., Laval, F. & Gairin, J. E. Localization of two cytotoxic T lymphocyte epitopes and three anchoring residues on a single nonameric peptide that binds to H-2L
pubmed: 7525302
Shanker, A. et al. CD8 T cell help for innate antitumor immunity. J. Immunol. 179, 6651–6662 (2007).
pubmed: 17982055
Giordano, M. et al. Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustion. EMBO J. 34, 2042–2058 (2015).
pubmed: 26139534 pmcid: 4551351
Giordano, M. et al. The tumor necrosis factor α-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells. Proc. Natl Acad. Sci. USA 111, 11115–11120 (2014).
pubmed: 25024217 pmcid: 4121810
Tong, E. H. et al. Regulation of nucleocytoplasmic trafficking of transcription factor OREBP/TonEBP/NFAT5. J. Biol. Chem. 281, 23870–23879 (2006).
pubmed: 16782704
Martinez, G. J. et al. The transcription factor NFAT promotes exhaustion of activated CD8
pubmed: 25680272 pmcid: 4346317
Chen, J. et al. NR4A transcription factors limit CAR T cell function in solid tumours. Nature 567, 530–534 (2019).
pubmed: 30814732 pmcid: 6546093
Berga-Bolanos, R., Alberdi, M., Buxade, M., Aramburu, J. & Lopez-Rodriguez, C. NFAT5 induction by the pre-T-cell receptor serves as a selective survival signal in T-lymphocyte development. Proc. Natl Acad. Sci. USA 110, 16091–16096 (2013).
pubmed: 24043824 pmcid: 3791764
Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189–196 (2016).
pubmed: 27124452 pmcid: 4944528
Scott, A. C. et al. TOX is a critical regulator of tumour-specific T cell differentiation. Nature 571, 270–274 (2019).
pubmed: 31207604 pmcid: 7698992
Chamoto, K., Yaguchi, T., Tajima, M. & Honjo, T. Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1. Nat. Rev. Immunol. https://doi.org/10.1038/s41577-023-00867-9 , (2023).
Wherry, E. J. et al. Molecular signature of CD8
pubmed: 17950003
Charmoy, M., Wyss, T., Delorenzi, M. & Held, W. PD-1
pubmed: 34496259
Kumar, R. et al. NFAT5, which protects against hypertonicity, is activated by that stress via structuring of its intrinsically disordered domain. Proc. Natl Acad. Sci. USA 117, 20292–20297 (2020).
pubmed: 32747529 pmcid: 7443939
Drews-Elger, K., Ortells, M. C., Rao, A., Lopez-Rodriguez, C. & Aramburu, J. The transcription factor NFAT5 is required for cyclin expression and cell cycle progression in cells exposed to hypertonic stress. PLoS ONE 4, e5245 (2009).
pubmed: 19381288 pmcid: 2667631
Conzelmann, A., Corthesy, P., Cianfriglia, M., Silva, A. & Nabholz, M. Hybrids between rat lymphoma and mouse T cells with inducible cytolytic activity. Nature 298, 170–172 (1982).
pubmed: 6979720
Verdeil, G., Chaix, J., Schmitt-Verhulst, A. M. & Auphan-Anezin, N. Temporal cross-talk between TCR and STAT signals for CD8 T cell effector differentiation. Eur. J. Immunol. 36, 3090–3100 (2006).
pubmed: 17111352
Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417–419 (2017).
pubmed: 28263959 pmcid: 5600148
Hunt, S. E. et al. Ensembl variation resources. Database 2018, bay119 (2018).
pubmed: 30576484 pmcid: 6310513
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281 pmcid: 4302049
Soneson, C., Love, M. I. & Robinson, M. D. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res 4, 1521 (2015).
pubmed: 26925227
Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083–1086 (2017).
pubmed: 28991892 pmcid: 5937676
Huynh-Thu, V. A., Irrthum, A., Wehenkel, L. & Geurts, P. Inferring regulatory networks from expression data using tree-based methods. PLoS ONE 5, e12776 (2010).
pubmed: 20927193 pmcid: 2946910
Herrmann, C., Van de Sande, B., Potier, D. & Aerts, S. i-cisTarget: an integrative genomics method for the prediction of regulatory features and cis-regulatory modules. Nucleic Acids Res. 40, e114 (2012).
pubmed: 22718975 pmcid: 3424583
Imrichova, H., Hulselmans, G., Atak, Z. K., Potier, D. & Aerts, S. i-cisTarget 2015 update: generalized cis-regulatory enrichment analysis in human, mouse and fly. Nucleic Acids Res. 43, W57–W64 (2015).
pubmed: 25925574 pmcid: 4489282
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587 (2021).
pubmed: 34062119 pmcid: 8238499
Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov. 2, 100141 (2021).
Andreatta, M. & Carmona, S. J. UCell: robust and scalable single-cell gene signature scoring. Comput Struct. Biotechnol. J. 19, 3796–3798 (2021).
pubmed: 34285779 pmcid: 8271111

Auteurs

Laure Tillé (L)

Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.
Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.

Daniela Cropp (D)

Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.
Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.

Mélanie Charmoy (M)

Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.

Patrick Reichenbach (P)

Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.
Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.

Massimo Andreatta (M)

Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.
Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.
SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.

Tania Wyss (T)

SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.

Gabrielle Bodley (G)

Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.

Isaac Crespo (I)

Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.
Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.
SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.

Sina Nassiri (S)

Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.
SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.

Joao Lourenco (J)

SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.

Marine M Leblond (MM)

Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.
Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.

Cristina Lopez-Rodriguez (C)

Immunology Unit, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.

Daniel E Speiser (DE)

Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.

George Coukos (G)

Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.
Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.

Melita Irving (M)

Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.
Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.

Santiago J Carmona (SJ)

Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.
Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland.
SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.

Werner Held (W)

Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland.

Grégory Verdeil (G)

Department of Oncology, UNIL CHUV, University of Lausanne, Lausanne, Switzerland. gregory.verdeil@unil.ch.
Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland. gregory.verdeil@unil.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH